Literature DB >> 22736928

WWOX induces apoptosis and inhibits proliferation of human hepatoma cell line SMMC-7721.

Ben-Shun Hu1, Jing-Wang Tan, Guo-Hua Zhu, Dan-Feng Wang, Xian Zhou, Zhi-Qiang Sun.   

Abstract

AIM: To investigate the effects of the WWOX gene on the human hepatic carcinoma cell line SMMC-7721.
METHODS: Full-length WWOX cDNA was amplified from normal human liver tissues. Full-length cDNA was subcloned into pEGFP-N1, a eukaryotic expression vector. After introduction of the WWOX gene into cancer cells using liposomes, the WWOX protein level in the cells was detected through Western blotting. Cell growth rates were assessed by methyl thiazolyl tetrazolium (MTT) and colony formation assays. Cell cycle progression and cell apoptosis were measured by flow cytometry. The phosphorylated protein kinase B (AKT) and activated fragments of caspase-9 and caspase-3 were examined by Western blotting analysis.
RESULTS: WWOX significantly inhibited cell proliferation, as evaluated by the MTT and colony formation assays. Cells transfected with WWOX showed significantly higher apoptosis ratios when compared with cells transfected with a mock plasmid, and overexpression of WWOX delayed cell cycle progression from G1 to S phase, as measured by flow cytometry. An increase in apoptosis was also indicated by a remarkable activation of caspase-9 and caspase-3 and a dephosphorylation of AKT (Thr308 and Ser473) measured with Western blotting analysis.
CONCLUSION: Overexpression of WWOX induces apoptosis and inhibits proliferation of the human hepatic carcinoma cell line SMMC-7721.

Entities:  

Keywords:  Apoptosis; Hepatic carcinoma; Proliferation; SMMC-7721; WWOX

Mesh:

Substances:

Year:  2012        PMID: 22736928      PMCID: PMC3380332          DOI: 10.3748/wjg.v18.i23.3020

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization.

Authors:  Damien Arnoult; Brigitte Gaume; Mariusz Karbowski; Juanita C Sharpe; Francesco Cecconi; Richard J Youle
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

2.  Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.

Authors:  G Rena; A R Prescott; S Guo; P Cohen; T G Unterman
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

3.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy.

Authors:  H Strik; M Deininger; J Streffer; E Grote; J Wickboldt; J Dichgans; M Weller; R Meyermann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-12       Impact factor: 10.154

5.  The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2.

Authors:  A L Hsu; T T Ching; D S Wang; X Song; V M Rangnekar; C S Chen
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

6.  Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway.

Authors:  M T Lin; R C Lee; P C Yang; F M Ho; M L Kuo
Journal:  J Biol Chem       Date:  2001-10-03       Impact factor: 5.157

7.  WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.

Authors:  Sai Yendamuri; Tamotsu Kuroki; Francesco Trapasso; Adam C Henry; Kristoffel R Dumon; Kay Huebner; Noel N Williams; Larry R Kaiser; Carlo M Croce
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

8.  Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.

Authors:  Keltouma Driouch; Hans Prydz; Rossana Monese; Henning Johansen; Rosette Lidereau; Eirik Frengen
Journal:  Oncogene       Date:  2002-03-14       Impact factor: 9.867

9.  Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.

Authors:  Tamotsu Kuroki; Francesco Trapasso; Takeshi Shiraishi; Hansjuerg Alder; Koshi Mimori; Masaki Mori; Carlo M Croce
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

10.  Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis.

Authors:  Rami I Aqeilan; John P Hagan; Alain de Bruin; Maysoon Rawahneh; Zaidoun Salah; Eugenio Gaudio; Hasan Siddiqui; Stefano Volinia; Hansjuerg Alder; Jane B Lian; Gary S Stein; Carlo M Croce
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

View more
  14 in total

1.  WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.

Authors:  Dong Wei; Xiaowen Zhang; Hao Zou; Lin Wang; Bimang Fu; Xuesong Wu; Zhiling Luo; Xiao Li; Jiayun Ge; Yuehua Li; Hong Zhu; Kun Wang; Tao Wang; Pei Yang; Zongliu Hou; Wenju Wang
Journal:  Tumour Biol       Date:  2013-10-15

Review 2.  Alteration of WWOX in human cancer: a clinical view.

Authors:  Izabela Baryła; Ewa Styczeń-Binkowska; Andrzej K Bednarek
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-13

Review 3.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

4.  WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase.

Authors:  Jen-Tai Lin; Hao-Yi Li; Nan-Shan Chang; Cheng-Han Lin; Yu-Chia Chen; Pei-Jung Lu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Reduced expression of the WW domain-containing oxidoreductase in human hematopoietic malignancies.

Authors:  Lingqing Luo; Yan Chen; Xiao Cheng; Yazhen Lin; Xiaodan Fu; Dan Li; Zhaolei Cui; Donghong Lin
Journal:  Oncol Lett       Date:  2016-04-26       Impact factor: 2.967

6.  Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas.

Authors:  Ming-Fu Chiang; Pei-Yi Chou; Wan-Jen Wang; Chun-I Sze; Nan-Shan Chang
Journal:  Front Oncol       Date:  2013-03-04       Impact factor: 6.244

7.  Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.

Authors:  Candy Kumps; Annelies Fieuw; Pieter Mestdagh; Björn Menten; Steve Lefever; Filip Pattyn; Sara De Brouwer; Tom Sante; Johannes Hubertus Schulte; Alexander Schramm; Nadine Van Roy; Tom Van Maerken; Rosa Noguera; Valérie Combaret; Christine Devalck; Frank Westermann; Geneviève Laureys; Angelika Eggert; Jo Vandesompele; Katleen De Preter; Frank Speleman
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

8.  Tumor Suppressor WWOX Contributes to the Elimination of Tumorigenic Cells in Drosophila melanogaster.

Authors:  Louise V O'Keefe; Cheng Shoou Lee; Amanda Choo; Robert I Richards
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

9.  Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines.

Authors:  Magdalena Nowakowska; Karolina Pospiech; Urszula Lewandowska; Agnieszka W Piastowska-Ciesielska; Andrzej Kazimierz Bednarek
Journal:  Tumour Biol       Date:  2014-06-19

10.  WWOX modulates the gene expression profile in the T98G glioblastoma cell line rendering its phenotype less malignant.

Authors:  Katarzyna Kośla; Magdalena Nowakowska; Karolina Pospiech; Andrzej K Bednarek
Journal:  Oncol Rep       Date:  2014-07-17       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.